Literature DB >> 18979632

Intestine-specific expression of green fluorescent protein-tagged cathepsin B: proof-of-principle experiments.

Kristina Mayer1, Maria E Iolyeva, Ulf Meyer-Grahle, Klaudia Brix.   

Abstract

We hypothesized that tissue-specific expression of cathepsin B-enhanced green fluorescent protein (CB-EGFP) can be driven by the A33-antigen promoter that contains positive cis-regulatory elements, including caudal-related homeobox (CDX) binding sites. The intestine-specific transcription factor Cdx1 is crucial for A33-antigen promoter activation and could thereby induce expression of CB-EGFP. This concept was tested by construction of the vector pA33-CathB-EGFP encoding CB-EGFP downstream of the A33-antigen promoter. Its Cdx1 dependence, as an indication of its intestine-specific expression, was tested in Cdx1-negative CHO-K1 cells. Cdx1 expression was achieved upon transfection with pCdx1-DsRed-Express and was indicated by red fluorescence of the simultaneously translated reporter protein. Immunolabeling with Cdx1-specific antibodies showed correct targeting of the transcription factor to its point of action in nuclei of transfected cells. Co-transfection experiments with plasmids pA33-CathB-EGFP and pCdx1-DsRed-Express confirmed the hypothesis that Cdx1 indeed activates CB-EGFP expression in a manner dependent on the A33-antigen promoter. Co-localization with compartment-specific markers and subcellular fractionation confirmed CB-EGFP trafficking along the expected route to endolysosomal compartments. Hence, the A33-antigen promoter represents a potent tool for induction of Cdx1-dependent CB-EGFP expression in vitro. Our proof-of-principle studies confirm the suitability of this approach in visualizing protease transport in Cdx1-positive tissues of the gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18979632     DOI: 10.1515/BC.2008.112

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  3 in total

1.  Gene and cell therapy based treatment strategies for inflammatory bowel diseases.

Authors:  Sander van der Marel; Anna Majowicz; Sander van Deventer; Harald Petry; Daniel W Hommes; Valerie Ferreira
Journal:  World J Gastrointest Pathophysiol       Date:  2011-12-15

2.  Cathepsin B trafficking in thyroid carcinoma cells.

Authors:  Sofia Tedelind; Silvia Jordans; Henrike Resemann; Galia Blum; Matthew Bogyo; Dagmar Führer; Klaudia Brix
Journal:  Thyroid Res       Date:  2011-08-03

3.  Construction of a plasmid coding for green fluorescent protein tagged cathepsin L and data on expression in colorectal carcinoma cells.

Authors:  Tripti Tamhane; Brit K Wolters; Rukshala Illukkumbura; Gunhild M Maelandsmo; Mads H Haugen; Klaudia Brix
Journal:  Data Brief       Date:  2015-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.